SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021Anthony Etyang, Ambrose Agweyu, James Tuju et al.|PLOS Global Public Health|2022Cited by 34
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022E. Wangeci Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|Influenza and Other Respiratory Viruses|2023Cited by 24
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in KenyaE. Wangeci Kagucia, John N. Gitonga, Catherine Kalu et al.|Open Forum Infectious Diseases|2021Cited by 20
Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in KenyaE. Wangeci Kagucia, Shirine Voller, John N. Gitonga et al.|medRxiv|2021Cited by 16
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022EW Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|medRxiv|2022Cited by 9